Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q2 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- XTEND delivers hundreds of M6F drone systems to Asia-Pacific military
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
